Lauri Urvas

The aim of my professional life is to contribute to successful drug discovery projects in the pharmaceutical industry. Currently a PhD student, I have over 3 years of experience in molecular modelling of GPCRs including their receptor-ligand interactions, my main research interest. Experienced also in pharmacology research and organic synthesis, I have a good understanding of the field of drug discovery.

• Leino TO, Turku A, Urvas L, Adhikari K, Oksanen J, Steynen Y, Yli-Kauhaluoma J, Xhaard H, Kukkonen JP, Wallén EAA. Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists. Manuscript. 2023

• Svarcbahs R, Jäntti M, Kilpeläinen T, Julku UH, Urvas L, Kivioja S, Norrbacka S, Myöhänen TT. Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A. Pharmacol Res. 2020;151:104558.

• Tähkä S, Sarfaz J, Urvas L, Provenzani R, Wiedmer SK, Peltonen J, Jokinen VP, Sikanen TM. Immobilization of proteolytic enzymes on replica-molded thiol-ene micropillar reactors via thiol-gold interaction. Anal Bioanal Chem. 2019;411(11):2339-2349.

• Kiiski IMA, Pihlaja T, Urvas L, Witos J, Wiedmer SK, Jokinen VP, Sikanen TM. Overcoming the Pitfalls of Cytochrome P450 Immobilization through the Use of Fusogenic Liposomes. Adv Biosyst. 2019;3(1):e1800245.

• Poster prize: i-GPCRnet Prize 2022, 2nd international meeting of the IRN i-GPCRnet
• Award of the Finnish pharmaceutical society for graduating with the highest grades among the Master of Science in Pharmacy graduates from the Faculty of Pharmacy, University of Helsinki in 2020

Esther Kellenberger

University of Strasbourg, Deputy Dean

+33 3 68 85 42 21

ekellen@unistra.fr

Henri Xhaard

University of Helsinki, Principal Investigator

Mobile: +358 50 448 0878

Email: henri.xhaard@helsinki.fi